Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v30-EN Version v12-EN
Language English English
Date Updated 2021-06-22 2021-05-04
Drug Identification Number 02312301 02312301
Brand name KALETRA KALETRA
Common or Proper name lopinavir/ritonavir tablets lopinavir/ritonavir tablets
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients LOPINAVIR RITONAVIR LOPINAVIR RITONAVIR
Strength(s) 100MG 25MG 100MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 Tablets bottle 60 Tablets bottle
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-06-21 2021-06-04
Actual start date 2021-06-21
Estimated end date 2021-06-22 2021-07-05
Actual end date 2021-06-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments As a result of an increase in demand for KALETRA® (lopinavir/ritonavir film-coated tablets, 100/25mg), we are closely monitoring our inventory of KALETRA film-coated tablets (100/25mg). KALETRA film-coated tablets (200/50 mg) and KALETRA oral solution (80/20 mg/mL) continue to be available. Should you have any questions, please contact our Customer Service Department at 1-888-704-8270. As a result of an increase in demand for KALETRA® (lopinavir/ritonavir film-coated tablets, 100/25mg), we are closely monitoring our inventory of KALETRA film-coated tablets (100/25mg). KALETRA film-coated tablets (200/50 mg) and KALETRA oral solution (80/20 mg/mL) continue to be available. Should you have any questions, please contact our Customer Service Department at 1-888-704-8270.
Health Canada comments